Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

[Therapeutic efficacy of youdujing preparation in treating cervical high-risk human papilloma virus infection patients].

Xiao J, Wu J, Yu B.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2012 Sep;32(9):1212-5. Chinese.

PMID:
23185761
2.

Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high-risk human papillomavirus, virus persistence, or disease outcome in cervical cancer.

Branca M, Giorgi C, Ciotti M, Santini D, Di Bonito L, Costa S, Benedetto A, Bonifacio D, Di Bonito P, Paba P, Accardi L, Mariani L, Ruutu M, Syrjänen S, Favalli C, Syrjänen K.

Diagn Cytopathol. 2006 Nov;34(11):739-48.

PMID:
17041957
3.

The role of human telomerase catalytic subunit mRNA expression in cervical dysplasias.

Tsezou A, Oikonomou P, Kollia P, Mademtzis I, Kostopoulou E, Messinis I, Vamvakopoulos N.

Exp Biol Med (Maywood). 2005 Apr;230(4):263-70.

PMID:
15792948
4.

Gene expression profiling to identify markers associated with deregulated hTERT in HPV-transformed keratinocytes and cervical cancer.

de Wilde J, Wilting SM, Meijer CJ, van de Wiel MA, Ylstra B, Snijders PJ, Steenbergen RD.

Int J Cancer. 2008 Feb 15;122(4):877-88.

5.

Physical state and expression of HPV DNA in benign and dysplastic cervical tissue: different levels of viral integration are correlated with lesion grade.

Hudelist G, Manavi M, Pischinger KI, Watkins-Riedel T, Singer CF, Kubista E, Czerwenka KF.

Gynecol Oncol. 2004 Mar;92(3):873-80.

PMID:
14984955
6.

DNA methylation is not likely to be responsible for hTERT expression in premalignant cervical lesions.

Oikonomou P, Messinis I, Tsezou A.

Exp Biol Med (Maywood). 2007 Jul;232(7):881-6.

PMID:
17609503
7.

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer.

Kailash U, Soundararajan CC, Lakshmy R, Arora R, Vivekanandhan S, Das BC.

Br J Cancer. 2006 Nov 6;95(9):1250-7. Epub 2006 Oct 24.

9.

Cytoplasmic poly(A) binding proteins regulate telomerase activity and cell growth in human papillomavirus type 16 E6-expressing keratinocytes.

Katzenellenbogen RA, Vliet-Gregg P, Xu M, Galloway DA.

J Virol. 2010 Dec;84(24):12934-44. doi: 10.1128/JVI.01377-10. Epub 2010 Oct 13.

10.
12.

Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA.

Petrenko AA, Korolenkova LI, Skvortsov DA, Fedorova MD, Skoblov MU, Baranova AV, Zvereva ME, Rubtsova MP, Kisseljov FL.

Biochimie. 2010 Dec;92(12):1827-31. doi: 10.1016/j.biochi.2010.07.015. Epub 2010 Aug 5.

PMID:
20691751
13.

Human papillomavirus DNA and mRNA positivity of the anal canal in women with lower genital tract HPV lesions: predictors and clinical implications.

Valari O, Koliopoulos G, Karakitsos P, Valasoulis G, Founta C, Godevenos D, Dova L, Paschopoulos M, Loufopoulos A, Paraskevaidis E.

Gynecol Oncol. 2011 Sep;122(3):505-8. doi: 10.1016/j.ygyno.2011.05.033. Epub 2011 Jun 12.

PMID:
21665253
15.

The relationship between the cervical and anal HPV infection in women with cervical intraepithelial neoplasia.

Sehnal B, Dusek L, Cibula D, Zima T, Halaska M, Driak D, Slama J.

J Clin Virol. 2014 Jan;59(1):18-23. doi: 10.1016/j.jcv.2013.11.004. Epub 2013 Nov 23.

PMID:
24315797
16.

[Effect of xunxi no.1 intervention and radiotherapy on Ia-IIb stage cervical cancer with high-risk human papilloma virus infection].

Zhang PY, Liu L, Wang XB.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2011 Aug;31(8):1066-9. Chinese.

PMID:
21910336
17.

[Progress of study on anti-human cervical papilloma virus infection with Chinese and Western medicine].

Li MC, Liu W, Shao WR.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007 Jun;27(6):573-5. Review. Chinese.

PMID:
17633379
18.
19.
20.

[Relationship between nitric oxide in cervical microenvironment and different HPV types and effect on cervical cancer cells].

Wei XM, Wang Q, Gao SJ, Sui L.

Zhonghua Fu Chan Ke Za Zhi. 2011 Apr;46(4):260-5. Chinese.

PMID:
21609578

Supplemental Content

Support Center